Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the human growth hormone market?

The size of the market for human growth hormone has expanded swiftly in recent time. The growth is projected to elevate from a worth of $4.75 billion in 2024 to $5.23 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 10.1%. The surging growth over the past period is linked to an increase in the occurrence of growth disorders, enhanced understanding of hormone therapies, their widening use in the field of sports medicine, an increasing elderly population, and improvements in healthcare infrastructure.

What will be the human growth hormone market size in the future?

Expectations are strong for healthy growth in the human growth hormone market size in the coming years. It is projected to reach $7.6 billion by 2029, with a compound annual growth rate (CAGR) of 9.8%. The predicted growth during this forecast period can be linked to the advent of personalized medicine, global increase in healthcare expenditure, more widespread use of recombinant DNA technology, and an increasing demand for hormone replacement therapies due to the increasing incidence of endocrine disorders. The forecast period is also likely to witness significant trends such as the broadening of distribution networks in burgeoning markets, the integration of artificial intelligence into drug development, a focus on sustainable manufacturing processes, the emergence of long-lasting formulations, along with the use of combination therapies for better efficacy.

Get your human growth hormone market report here!

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

What main drivers are fueling expansion in the human growth hormone market?

The escalating consciousness regarding treatment procedures is anticipated to boost the upward trajectory of the human growth hormone market. Treatment procedures are medical strategies devised to soothe, manage, or eradicate health ailments or diseases. This increasing knowledge of treatment processes is credited to advances in medical technology, easier access to data via digital media and a burgeoning public interest in health and wellness. Human growth hormone (HGH) therapies have drawn notable media coverage and public fascination, underscoring the advantages and potential uses of contemporary medical procedures, thus heightening general understanding of treatment techniques. For instance, in November 2023, The 2022 National Survey on Drug Use and Health (NSDUH) report presented by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US Department of Health and Human Services affirmed that in 2021, 40.6% of adolescents aged 12 to 17 out of the 5.0 million with a suffering a past year Major Depressive Episode (MDE) took treatment for depression, while in 2022, 56.8% of the 4.8 million adolescents with a similarly past year MDE took mental health treatment. Hence, the amplified consciousness of treatment procedures is facilitating the growth of the human growth hormone market. Healthcare expenditure, on an uptrend, is likely to thrust the growth of the human growth hormone market. The term refers to the cumulative outlay on health facilities, products, and interventions targeting health enhancement and preservation. Human growth hormone (HGH) treatment represents a novel pathway to curtail healthcare expenditure, by addressing the basic health issues that influence long-term costs, reinforcing recovery and life quality, and possibly preventing the emergence of pricey chronic aliments. For instance, a report issued by the Office for National Statistics, a UK government department in May 2023, showcased that the UK witnessed an increment in healthcare spending by 5.6% between 2022 and 2023, compared with a growth of 0.9% in 2022, putting the UK healthcare expenditure at roughly $317.63 billion (£292 billion) in 2023. As a result, the upward thrust in healthcare expenditure is propelling the human growth hormone market.

What key areas define the segmentation of the global human growth hormone market?

The human growth hormone market covered in this report is segmented –

1) By Product: Liquid, Powder

2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Others Brands

3) By Route Of Administration: Oral, Intravenous, Intramuscular, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy

5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications

Subsegments:

1) By Liquid: Pre-Filled Liquid Syringes, Vials Of Liquid Growth Hormone

2) By Powder: Reconstitutable Powder, Freeze-Dried Powder

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp

Who are the dominant players expanding their reach in the human growth hormone market?

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., Shanghai United Imaging Healthcare Co. Ltd., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

What key trends are currently impacting the human growth hormone market’s development?

Leading firms in the human growth hormone market are amplifying their efforts towards drug development and securing approvals in order to enhance their medicinal offerings and deliver superior treatment solutions. Developing a drug is an intricate and stringent process comprised of multiple stages to guarantee the safety, effectiveness, and quality of a new medication before it is introduced to the market. For example, in June 2023, both Pfizer Inc., a biopharmaceutical firm based in the US, and OPKO Health Inc., a US-based biopharmaceutical and diagnostics firm, obtained the approval for NGENLA (somatrogon-ghla) from the Food and Drug Administration (FDA). This treatment provides a more manageable dosing schedule and enhances patient compliance compared to daily injections. It affords children with growth hormone deficiency an opportunity to lessen the injection frequency from daily to weekly. The FDA’s approval was bolstered by a Phase 3 study that demonstrated NGENLA’s non-inferiority as compared to once-daily somatropin, and it exhibited a safety profile tantamount to somatropin.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15825

Which regions are emerging as leaders in the human growth hormone market?

North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Human Machine Interface Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/human-machine-interface-global-market-report

Parathyroid Hormone Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Hormone Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: